Close
Help
Login
Staff Login
Register
FR
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP137449971 | FDA panel endorses booster for single-shot vaccine
CP137437671 | FDA panel debates booster for single-dose vaccine
CP137329422 | FDA panel debates lower-dose Moderna COVID booster
CP137360871 | FDA panel backs lower-dose Moderna COVID booster
CP153540072 | FDA: 50 and up can get 2nd Pfizer, Moderna booster
FDA panel questions Janssen data in booster debate
Johnson & Johnson executives have pitched a booster as a way to strengthen a robust vaccine that they said has retained its protective power over eight months. But FDA scientists pointedly challenged that assertion on Friday. (Oct. 15)
Actions
Add to collection
Add to cart
Information
Source name:
The Associated Press
Unique identifier:
CP137447922
Legacy Identifier:
c31a5473683740dfa8238e3afb77c7e1
Type:
Video
Duration:
1m26s
Dimensions:
1920px × 1080px 106.08 MB
Usage rights:
Digital platform use only. Broadcast rights and editing of content prohibited.
Create Date:
10/15/2021 1:35:40 PM
Display aspect ratio:
16:9